Chemours
CC · NYSE · Materials · United States
Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:27 PM
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Market cap
$2.7B
Day change
+1.9%
Fwd P/E
8.2
P/B
12.8
Div yield
1.95%
Beta
1.40
Revenue (FY2025)
$5.8B
Net margin
-6.6%
ROE
-68.2%
Revenue CAGR (2y)
-2.2%
EPS (FY2025)
-2.57
Net profit (FY2025)
$-386.0M
Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.
Ask MarketChacha about CC
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $5.8B | $-386.0M | -2.57 | -6.6% | -68.2% |
| FY2024 | $5.8B | $69.0M | 0.46 | 1.2% | 12.1% |
| FY2023 | $6.1B | $-253.0M | -1.70 | -4.2% | -35.1% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q1 | $1.4B | $-29.0M | -0.19 | -2.1% |
| 2025Q4 | $1.3B | $-47.0M | -0.31 | -3.5% |
| 2025Q3 | $1.5B | $46.0M | 0.31 | 3.1% |
| 2025Q2 | $1.6B | $-380.0M | -2.53 | -23.5% |
| 2025Q1 | $1.4B | $-5.0M | -0.03 | -0.4% |
| 2024Q4 | $1.4B | $-11.0M | -0.08 | -0.8% |
| 2024Q3 | $1.5B | $-32.0M | -0.22 | -2.1% |
| 2024Q2 | $1.6B | $60.0M | 0.39 | 3.9% |
| 2024Q1 | $1.4B | $54.0M | 0.36 | 4.0% |
| 2023Q4 | $1.4B | $-18.0M | -0.12 | -1.3% |
| 2023Q3 | $1.5B | $12.0M | 0.08 | 0.8% |
| 2023Q2 | $1.7B | $-376.0M | -2.52 | -22.7% |
| 2023Q1 | $1.5B | $145.0M | 0.96 | 9.4% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC6/24/2026material
- SEC5/5/2026material
- SEC5/5/2026
- SEC4/30/2026material
In the news
- Chemours (CC) Stock Looks Below Fair Value Even After A 51% Runsimplywall.st · 7/16/2026
- 4 Best Titanium Stocks for 2026 and How to InvestThe Motley Fool · 7/13/2026
- Is Chemours (CC) A Bargain As Its PFAS Settlement Clarifies Long Term Risks?simplywall.st · 7/2/2026
- CC Forecast — Price Target — Prediction for 2027TradingView · 6/25/2026
- Truist Financial Reaffirms Their Buy Rating on Chemours Company (CC)The Globe and Mail · 6/18/2026
- Chemours (CC) Shares Drop as EPA Eases Refrigerant RegulationsGuruFocus · 5/21/2026
- Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $3024/7 Wall St. · 5/15/2026
- Chemours’ Stock Jumped As Deleveraging Took Center StageFinimize · 5/8/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.